Media

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

https://investor.ironwoodpharma.com/press-releases/press-release-details/2017/Ironwood-Announces-New-Drug-Application-for-DUZALLO-Fixed-Dose-Combination-of-Lesinurad-and-Allopurinol-Has-Been-Accepted-for-FDA-Review/default.aspx

Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here